[1] Hassan M, Watari H, AbuAlmaaty A, et al. Apoptosis and molecular targeting therapy in cancer[J]. Biomed Res Int, 2014, 2014(2): 1-23. [2] Fulda S.Evasion of apoptosis as a cellular stress response in cancer[J]. Int J Cell Biol, 2010, 2010(22): 1-6. [3] Bratton SB, Salvesen GS.Regulation of the Apaf-1-caspase-9 apoptosome[J]. J Cell Scie, 2010, 123(Pt 19): 3209-3214. [4] Ekonomopoulou MT, Babas E, Mioglou-Kalouptsi E, et al.Changes in activities of caspase-8 and caspase-9 in human cervical malignancy[J]. Int J Gynecol Cancer, 2011, 21(3): 435-438. [5] Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, et al.Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics[J]. Pancreas, 2010, 39(7): 976-980. [6] Wang YX, Zhao L, Wang XY, et al.Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population[J]. Med Oncol, 2012, 29(4): 2445-2451. [7] Yoo NJ, Kim MS, Park SW, et al.Expression analysis of caspase-6, caspase-9 and BNIP3 in prostate cancer[J]. Tumori, 2010, 96(1): 138-142. [8] Fulda S, Vucic D.Targeting IAP proteins for therapeutic intervention in cancer[J]. Nat Rev Drug Discov, 2012, 11(2): 109-124. [9] Giardino Torchia ML, Conze DB, et al.c-IAP1 and c-IAP2 redundancy differs between T and B cells[J]. PLoS One, 2013, 8(6): e66161. [10] Krepela E, Dankaova P, Moravcikvoa E, et al.Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma[J]. Int J Oncol, 2009, 35(6): 1449-1462. [11] Tirro E, Consoli ML, Massimino M, et al.Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells[J]. Cancer Res, 2006, 66(8): 4263-4272. [12] Akyurek N, Ren Y, Rassidakis GZ, et al.Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas[J]. Cancer, 2006, 107(8): 1844-1851. [13] Ma O, Cai WW, Zender L, et al.MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression[J]. Cancer Res, 2009, 69(6): 2559-2567. [14] Tamm I, Kornblau SM, Segall H, et al.Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias[J]. Clin Cancer Res, 2000, 6(5): 1796-1803. |